作者:
Goren,Saenz-Pipaon [1]
;
Patxi,San Martín [2]
;
Núria,Planell [3]
;
Alberto,Maillo [4]
;
Susana,Ravassa [4]
;
Amaia,Vilas-Zornoza [2]
;
Esther,Martinez-Aguilar [5]
;
José Antonio,Rodriguez [6]
;
Daniel,Alameda [3]
;
David,Lara-Astiaso [7]
;
Felipe,Prosper [2]
;
José Antonio,Paramo [8]
;
Josune,Orbe [1]
;
David,Gomez-Cabrero [2]
;
Carmen,Roncal [6]
作者单位:
Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, Cima Universidad de Navarra, Pamplona, Spain.
[1]
IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.
[2]
Oncohematology Program, Cima Universidad de Navarra, Pamplona, Spain.
[3]
Translational Bioinformatics Unit, Navarrabiomed, Pamplona, Spain.
[4]
Laboratory of Heart Failure, Program of Cardiovascular Diseases, Cima Universidad de Navarra, Pamplona, Spain.
[5]
CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.
[6]
CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
[7]
Departamento de Angiología y Cirugía Vascular, Complejo Hospitalario de Navarra, Pamplona, Spain.
[8]
Stem Cell Institute, MRC, Cambridge, UK.
[9]
Hematology Service, Clínica Universidad de Navarra, Pamplona, Spain.
[10]
DOI
10.1080/20013078.2020.1729646
PMID
32158521
发布时间
2020-09-28